Wells Fargo
EW icon

Wells Fargo’s Edwards Lifesciences EW Stock Holding History

Wells Fargo’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-107,000
Closed -$7.76M – 7209
2025
Q1 		$7.76M Buy
+107,000
New +$7.66M ﹤0.01% 2067
2022
Q1 		– Sell
-200
Closed -$26K – 7252
2021
Q4 		$26K Buy
+200
New +$23.3K ﹤0.01% 6234

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo's EW Position: Q1 2026 in Review

Wells Fargo reduced its Edwards Lifesciences (EW) stake by 0.05% in Q1 2026, selling an estimated $47.9K and leaving 1,081,271 shares worth $86.6M. The position accounts for 0.02% of the portfolio, ranked #691.

Wells Fargo first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $483M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Wells Fargo held 1,081,271 shares of Edwards Lifesciences worth $86.6M as of Q1 2026.
  • Wells Fargo sold 581 Edwards Lifesciences shares in Q1 2026, an estimated $47.9K.
  • Edwards Lifesciences made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #691 holding.
  • Wells Fargo first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Edwards Lifesciences position peaked at $483M in Q2 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.